For the year ending 2025-12-31, DFPH has $164,656K in assets. $180,376K in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 33,565 | |||
| Accounts receivable, net | 58,998 | |||
| Other receivables | 322 | |||
| Inventories | 16,875 | |||
| Prepaid expenses and other current assets | 2,987 | |||
| Total current assets | 112,747 | |||
| Property and equipment, net | 10,684 | |||
| Operating right of use assets | 22,374 | |||
| Intangible assets, net | 11,015 | |||
| Goodwill | 7,230 | |||
| Other assets | 606 | |||
| Total assets | 164,656 | |||
| Accounts payable | 43,167 | |||
| Current portion of operating lease liabilities | 7,156 | |||
| Accrued expenses and other current liabilities | 20,639 | |||
| Total current liabilities | 70,962 | |||
| Operating lease liabilities | 19,131 | |||
| Derivative warrant liabilities | 264 | |||
| Conversion option derivative liabilities | 12,591 | |||
| Long-term debt, net of unamortized debt issuance costs | 77,400 | |||
| Other non-current liabilities | 28 | |||
| Deferred income taxes liability | 0 | |||
| Total liabilities | 180,376 | |||
| Common stock, 0.0001 par value, authorized 500,000,000 shares 100,596,918 shares issued and 98,863,144 shares outstanding at december31, 2025 and 77,470,886 shares issued and 75,737,112 shares outstanding at december31, 2024 | 10 | |||
| Additional paid-in capital | 256,708 | |||
| Treasury stock at cost, 1,733,774 shares at december31, 2025 and 2024 | 1,019 | |||
| Accumulated deficit | -271,419 | |||
| Total stockholders equity (deficit) | -15,720 | |||
| Total liabilities and stockholders equity (deficit) | 164,656 | |||
Oncology Institute, Inc. (DFPH)
Oncology Institute, Inc. (DFPH)